Richard T Silver

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Metastatic Renal Cell Carcinoma

Pulmonary Embolism

Prognostic Factors

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T Silver, Joseph M Scandura
Are thrombosis, progression, and survival in ET predictable? Blood cancer journal 14 (1) (2024)
Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T Silver, Joseph M Scandura
Are thrombosis, progression, and survival in ET predictable? Blood cancer journal 14 (1) (2024)
Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T Silver, Joseph M Scandura
Are thrombosis, progression, and survival in ET predictable? Blood cancer journal 14 (1) (2024)
Richard T Silver, Katie Erdos, Elwood Taylor, Joseph Michael Scandura, Ghaith Abu-Zeinah
Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival. Leukemia (2022)
Richard T Silver, Katie Erdos, Elwood Taylor, Joseph Michael Scandura, Ghaith Abu-Zeinah
Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival. Leukemia 37 (3) (2022)
Richard T Silver, Katie Erdos, Elwood Taylor, Joseph Michael Scandura, Ghaith Abu-Zeinah
Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival. Leukemia 37 (3) (2022)
Richard T Silver, Katie Erdos, Elwood Taylor, Joseph Michael Scandura, Ghaith Abu-Zeinah
Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival. Leukemia 37 (3) (2022)
Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Francesca Palandri, Valerio De Stefano, Marianna Caramella, Silvia Salmoiraghi, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, David Morrall Ross, Matteo G Della Porta, Timothy Devos, Giada Rotunno, Rami S Komrokji, Ilaria C Casetti, Michele Merli, Marco Brociner, Domenica Caramazza, Giuseppe Auteri, Tiziano Barbui, Daniele Cattaneo, Lorenza Bertù, Luca Arcaini, Alessandro M Vannucchi, Francesco Passamonti
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. Leukemia 36 (10) (2022)
Ghaith Abu-Zeinah, Spencer Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, Niamh Savage, Claudia Sosner, Ellen K Ritchie, Joseph Michael Scandura, Richard T Silver
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival. Leukemia 35 (9) (2021)
Ghaith Abu-Zeinah, Richard T Silver, Khalid Abu-Zeinah, Joseph Michael Scandura
Normal life expectancy for polycythemia vera (PV) patients is possible. Leukemia (2021)